Tianjin Ringpu Bio-Technology (300119.SZ) Earnings Analysis

Tianjin Ringpu Bio-Technology (300119.SZ) next reports earnings on 2026-08-26. Trailing P/E 18.61.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 300119.SZ next report earnings?

Next earnings date2026-08-26
Consensus EPS estimaten/a
Revenue estimate0.85B

300119.SZ earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-230.23 CNYn/an/an/a
2026-03-310.08 CNYn/an/an/a
2025-10-240.23 CNYn/an/an/a
2025-04-260.1216 CNYn/an/an/a
2025-04-020.2549 CNYn/an/an/a
2024-08-230.1555 CNYn/an/an/a

300119.SZ valuation and analyst view

Trailing P/E18.61
Trailing EPS0.86412 CNY
Price / book1.52
Dividend yield2.49%
Market cap7.40B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Tianjin Ringpu Bio-Technology (300119.SZ)'s next earnings date?

Tianjin Ringpu Bio-Technology is next scheduled to report on 2026-08-26 and revenue estimate of 0.85B.

Did 300119.SZ beat earnings last quarter?

Consensus estimate data was not available for 300119.SZ's 2026-04-23 report.

What is 300119.SZ's current P/E ratio and EPS?

300119.SZ trades at a trailing P/E of 18.61 on trailing EPS of 0.8641234994323187 CNY.

What do analysts rate 300119.SZ?

300119.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.